Veterinary Medicines

Canigen DHPPi/L

Not authorised
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
  • Canine parainfluenza virus, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle VR128, Live
Download as PDF

Product identification

Medicine name:
Canigen DHPPi/L
Active substance:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
  • Canine parainfluenza virus, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle VR128, Live
Target species:
  • Dog
  • Dog
Route of administration:
  • Subcutaneous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
    833000000.00
    cells
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
    833000000.00
    cells
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain Manhattan, Live
    100000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, strain Cornell 780916, Live
    100000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan, Live
    10000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine distemper virus, strain Lederle VR128, Live
    1000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac Tierarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 106a/92
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 19/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."